Growth Factor Gene-Modified Mesenchymal Stem Cells in Tissue Regeneration

Area of Science:

• Regenerative Medicine
• Biotechnology
• Cell Therapy

Background:

• Mesenchymal stem cells (MSCs) are widely used in regenerative medicine due to their safety.
• Current MSC therapies face limitations in engraftment and survival, hindering clinical utility.
• MSCs secrete growth factors crucial for tissue regeneration.

Purpose of the Study:

• To review recent advancements in producing and using growth factor gene-modified MSCs.
• To discuss the potential of these modified MSCs for tissue repair applications.
• To evaluate the prospects of genetically modified MSCs in clinical settings.

Main Methods:

• Engineering MSCs to express specific growth factors.
• Preclinical research evaluating the efficacy of modified MSCs in tissue damage models.
• Surveying recent approaches in growth factor gene modification of MSCs.

Main Results:

• Engineered MSCs demonstrate improved survival, proliferation, and differentiation.
• Preclinical studies indicate that modified MSCs effectively treat various forms of tissue damage.
• Growth factor expression enhances the tissue-reconstructing abilities of MSCs.

Conclusions:

• Genetically modified MSCs represent a significant advancement in regenerative therapy.
• These modified cells offer enhanced therapeutic potential for tissue repair.
• Further clinical application of growth factor-enhanced MSCs is anticipated.